AOD-9604 vs Semaglutide Oral
Comprehensive side-by-side comparison of mechanisms, dosing, side effects, and research
Also: Anti-Obesity Drug 9604, Tyr-hGH Fragment 177-191
A modified fragment of human growth hormone (amino acids 177-191) studied for fat metabolism effects without the broader hormonal effects of full GH.
Also: Rybelsus
The oral formulation of semaglutide using SNAC absorption enhancer. First oral GLP-1 receptor agonist FDA approved.
Key Comparison Insights
- Semaglutide Oral is FDA approved, while AOD-9604 remains in research stages.
- Both peptides belong to the Weight Loss category, suggesting similar primary applications.
- Semaglutide Oral has stronger research evidence (FDA Approved) compared to AOD-9604 (Human Trials).
Detailed Comparison
| Attribute | AOD-9604 | Semaglutide Oral |
|---|---|---|
| Category | Weight Loss | Weight Loss |
| FDA Status | Not FDA Approved | FDA Approved |
| Clinical Status | Pre I II III IV FDA | Pre I II III IV FDA |
| Mechanism of Action | AOD-9604 mimics the lipolytic (fat-burning) effects of growth hormone without affecting blood sugar or tissue growth. It stimulates lipolysis and inhibits lipogenesis by interacting with beta-3 adrenergic receptors on fat cells. | Same mechanism as injectable semaglutide but co-formulated with SNAC (sodium N-[8-(2-hydroxybenzoyl)amino]caprylate) which enhances absorption across stomach lining and protects from degradation. |
| Common Dosing | 300 mcg daily Once daily, usually morning fasted | Limited community data available See research protocols |
| Administration | Subcutaneous injection or oral (studied both) | Oral tablet on empty stomach with <4oz water |
| Typical Duration | 12-24 weeks in studies | Long-term / chronic use |
| Best Time to Take | Morning (fasted) | Before bed or morning (fasted) |
Possible Side Effects May vary by individual |
|
|
| Research Summary | Clinical trials showed modest weight loss effects but failed to meet primary endpoints for FDA approval. Some studies show cartilage regeneration potential. Research demonstrates safety profile similar to placebo with no significant GH-like side effects. | PIONEER program established efficacy for diabetes. Achieves 80% bioavailability of subcutaneous injection. Must be taken fasting with minimal water for optimal absorption. |
Frequently Asked Questions: AOD-9604 vs Semaglutide Oral
What is the difference between AOD-9604 and Semaglutide Oral?
AOD-9604 is a weight loss peptide that a modified fragment of human growth hormone (amino acids 177-191) studied for fat metabolism effects without the broader hormonal effects of full gh. Semaglutide Oral is a weight loss peptide that the oral formulation of semaglutide using snac absorption enhancer. first oral glp-1 receptor agonist fda approved. The main differences lie in their mechanisms of action and clinical applications.
Which is better, AOD-9604 or Semaglutide Oral?
Neither is universally "better" - the choice depends on your specific goals. AOD-9604 is typically used for weight loss purposes, while Semaglutide Oral is used for weight loss. Always consult with a healthcare provider to determine which may be appropriate for your situation.
Can AOD-9604 and Semaglutide Oral be used together?
Some peptide protocols combine multiple compounds for synergistic effects. However, using AOD-9604 and Semaglutide Oral together should only be considered under medical supervision, as both compounds have their own side effect profiles and potential interactions. Research on their combined use may be limited.
Related Comparisons
View Full Peptide Profiles
Educational Information Only
This comparison of AOD-9604 and Semaglutide Oral is for educational purposes only. Neither this comparison nor any information on this site constitutes medical advice. Always consult with qualified healthcare providers before making decisions about peptides or other substances.